EGCG inhibited MIA PaCa-2 and Panc-1 pancreatic cancer migration and invasion in vitro and in vivo through modulation of EMT demonstrated via the prevention of cadherin switch as well as a decrease in TCF8/ZEB1, β-Catenin and vimentin expression. Here, ZEB1 is linked to pancreatic neoplasm.